» Articles » PMID: 36364395

Evaluation of Antioxidant Activity and Biotransformation of Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Nov 11
PMID 36364395
Authors
Affiliations
Soon will be listed here.
Abstract

biological effects are attributed to several bioactive metabolites. However, these actions could be altered in vivo by biotransformation reactions mainly via gut microbiota. This study assessed gut microbiota effect on the biotransformation of metabolites both in vitro and ex vivo. Two-time aliquots (0.5 and 24 h) from the in vitro assay were harvested post incubation of methanol extract with microbial consortium, while untreated and treated samples with fecal bacterial culture from the ex vivo assay were prepared. Metabolites were analyzed using UHPLC-QTOF-MS, with flavonoid glycosides completely hydrolyzed in vitro at 24 h being converted to two major metabolites, 3-(4-hydroxyphenyl)propanoic acid and phloroglucinol, concurrent with an increase in the gallic acid level. In case of the ex vivo assay, detected flavonoid glycosides in untreated sample were completely absent from treated counterpart with few flavonoid aglycones and 3-(4-hydroxyphenyl)propanoic acid in parallel to an increase in piscidic acid. In both assays, fatty and organic acids were completely hydrolyzed being used as energy units for bacterial growth. Chemometric tools were employed revealing malic and (iso)citric acids as the main discriminating metabolites in vitro showing an increased abundance at 0.5 h, whereas in ex vivo assay, (iso)citric, aconitic and mesaconic acids showed an increase at untreated sample. Piscidic acid was a significant marker for the ex vivo treated sample. DPPH, ORAC and FRAP assays were further employed to determine whether these changes could be associated with changes in antioxidant activity, and all assays showed a decline in antioxidant potential post biotransformation.

Citing Articles

Assessment of Opuntia ficus-indica supplementation on enhancing antioxidant levels.

Zaman R, Tan E, Bustami N, Amini F, Seghayat M, Ho Y Sci Rep. 2025; 15(1):3507.

PMID: 39875543 PMC: 11775336. DOI: 10.1038/s41598-025-87680-7.


Profiling of primary and phytonutrients in edible mahlab cherry ( L.) seeds in the context of its different cultivars and roasting as analyzed using molecular networking and chemometric tools.

Mostafa M, Farag M PeerJ. 2023; 11:e15908.

PMID: 37663279 PMC: 10474835. DOI: 10.7717/peerj.15908.


Outstanding Antibacterial Activity of -Comparison of the Antimicrobial Effects of Extracts and Fractions from Four Species Growing in Bulgaria with a Focus on Prenylated Phloroglucinols.

Ilieva Y, Marinov T, Trayanov I, Kaleva M, Zaharieva M, Yocheva L Life (Basel). 2023; 13(2).

PMID: 36836632 PMC: 9959064. DOI: 10.3390/life13020274.

References
1.
Lee H, Jenner A, Low C, Lee Y . Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol. 2006; 157(9):876-84. DOI: 10.1016/j.resmic.2006.07.004. View

2.
Benzie I, Strain J . The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239(1):70-6. DOI: 10.1006/abio.1996.0292. View

3.
Lopez de Felipe F, de Las Rivas B, Munoz R . Bioactive compounds produced by gut microbial tannase: implications for colorectal cancer development. Front Microbiol. 2014; 5:684. PMC: 4257100. DOI: 10.3389/fmicb.2014.00684. View

4.
Zheng S, Geng D, Liu S, Wang Q, Liu S, Wang R . A newly isolated human intestinal bacterium strain capable of deglycosylating flavone C-glycosides and its functional properties. Microb Cell Fact. 2019; 18(1):94. PMC: 6537369. DOI: 10.1186/s12934-019-1144-7. View

5.
Javdan B, Lopez J, Chankhamjon P, Lee Y, Hull R, Wu Q . Personalized Mapping of Drug Metabolism by the Human Gut Microbiome. Cell. 2020; 181(7):1661-1679.e22. PMC: 8591631. DOI: 10.1016/j.cell.2020.05.001. View